Because of lack of neurological disease controls having overlapping or distinct clinical symptoms with ALS, the differences observed in CCR2 levels in the study may reflect the molecular change relevant to diseases of CNS in general, as opposed to ALS disease in specific. Here, CCR2 is linked to amyotrophic lateral sclerosis.